THOR MEDICAL ASA (TRMED.OL) Stock Income Statement
OSL:TRMED - Euronext Oslo - NO0010597883 - Common Stock - Currency: NOK
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 7.20M | 316.45M | 442.43M | 434.16M | 440.35M | |||
| Research and Development | 945.00K | 202.54M | N/A | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 4.91M | 108.21M | 91.64M | 78.30M | 96.41M | |||
| Operating Income | -7.20M | -316.45M | -442.43M | -434.16M | -440.35M | |||
| Interest Income/Expense | 1.77M | 7.08M | 2.44M | 18.39M | 7.93M | |||
| Other Income/Expense | -169.00K | -90.00K | -140.00K | -390.00K | -240.00K | |||
| Non Recurring Items | 41.00K | -910.00K | N/A | N/A | N/A | |||
| Income Before Taxes | -5.56M | -310.37M | -440.14M | -416.16M | -432.66M | |||
| Income Tax | 0.00 | 870.00K | 1.17M | 910.00K | 940.00K | |||
| Net Income | -26.56M | -311.24M | -441.30M | -417.08M | -433.60M | |||
| EBITDA | -6.48M | -305.25M | -431.06M | -419.26M | -427.69M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.15 | -2.70 | -4.65 | -5.95 | -7.58 | |||
| Non GAAP EPS | N/A | N/A | N/A | -5.91 | -7.47 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in NOK